BioMarin Pharmaceutical is a biotechnology company that develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Founded in 1997, BioMarin focuses on providing treatments that significantly improve the lives of patients with rare genetic diseases and other serious conditions. The company is dedicated to advancing the science of innovative therapeutics through a deep commitment to research and development.

Services include:
– Research and development of biopharmaceuticals
– Commercialisation of innovative therapeutics
– Treatments for rare genetic disorders
– Comprehensive support for patients and healthcare providers

BioMarin Pharmaceutical continues to lead in the biopharmaceutical industry by providing vital treatments for patients in need. For more information, visit bmrn.com.